| 标题 |
 Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: Efficacy and safety results from the 52-week, randomized, double-blinded, phase 3 Program fOr Evaluation of TYK2 inhibitor psoriasis second trial |
| 网址 | |
| DOI | |
| 其它 |
期刊：Journal of the American Academy of Dermatology 作者：Bruce Strober; Diamant Thaçi; Howard Sofen; Leon Kircik; Kenneth B. Gordon; et al 出版日期：2023-01-01 |
| 求助人 | |
| 下载 | 求助已完成，仅限求助人或该文件上传人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)
null
kaio_escolar
mmmm
酸味yjm
GingerF
雪之下
饱满书雁
v0id
无极微光
mmyhn
初景
DW
忧心的曼凝
极限001
OK
cocohan
吃葡萄不吐葡萄皮
渡人舟
勤劳丹翠
xiaoyinni
皖公网安备34019202002308
